STT
62
3
VRTX
53
5
RCL
68
4
CRM
70
18
IVZ
70
2
L
71
2
VIX
22
-14
AIV
37
-2
CAG
41
-5
BK
74
5
EXPD
51
16
PCG
74
2
WYNN
50
2
MMM
56
2
IP
28
-3
CME
45
3
JPM
70
3
MMC
53
-5
MAT
50
-5
HBAN
82
3
STT
62
3
VRTX
53
5
RCL
68
4
CRM
70
18
IVZ
70
2
L
71
2
VIX
22
-14
AIV
37
-2
CAG
41
-5
BK
74
5
EXPD
51
16
PCG
74
2
WYNN
50
2
MMM
56
2
IP
28
-3
CME
45
3
JPM
70
3
MMC
53
-5
MAT
50
-5
HBAN
82
3
Financhill
Back

Intellia Therapeutics, Inc. Vs. Ascendis Pharma A/S Industry Stock Comparison

Sell
19

NTLA
Intellia Therapeutics, Inc.

Last Price:
$9.24
Seasonality Move:
-6.88%
Sell
40

ASND
Ascendis Pharma A/S

Last Price:
$200.02
Seasonality Move:
19.56%
Sell
19
Intellia Therapeutics, Inc. (NTLA) is a Sell

Is Intellia Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Intellia Therapeutics, Inc. [NTLA] share price is $9.23. The Score for NTLA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Ascendis Pharma A/S (ASND) is a Sell

Is Ascendis Pharma A/S a Buy, Sell or Hold?

  • The current Ascendis Pharma A/S [ASND] share price is $199.99. The Score for ASND is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics, Inc.'s stock price today?

  • The Intellia Therapeutics, Inc. share price today is $9.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight buying pressure.

ASND Stock Price Chart

What is Ascendis Pharma A/S's stock price today?

  • The Ascendis Pharma A/S share price today is $199.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing slight buying pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 43.35 Sell
Chaikin Money Flow: 205899 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.36 - 9.34) Buy
Bollinger Bands (100): (8.08 - 18.94) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 44.76 Sell
Chaikin Money Flow: 14533 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (202.09 - 213.85) Sell
Bollinger Bands (100): (192.48 - 209.22) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.14 Buy
20-day SMA: 8.97 Buy
50-day SMA: 13.31 Sell
200-day SMA: 11.33 Sell
8-day EMA: 9.09 Buy
20-day EMA: 9.44 Sell
50-day EMA: 11.41 Sell
200-day EMA: 12.87 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 207.47 Sell
20-day SMA: 206.98 Sell
50-day SMA: 205.78 Sell
200-day SMA: 182.32 Buy
8-day EMA: 205.13 Sell
20-day EMA: 206.26 Sell
50-day EMA: 204.64 Sell
200-day EMA: 184.52 Buy

Intellia Therapeutics, Inc. Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.38 per share.

Ascendis Pharma A/S Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.00 per share, and an increase next year of $7.73 per share.

Intellia Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):